Table 2.
Demographic, clinical and laboratory parameters at presentation in surviving and dead patients
| Dead | Alive | P value | |
|---|---|---|---|
| Age (years) | (17) 56 ± 2.2 (42–74) | (25) 56.2 ± 2.8 (26–87) | 1.0 |
| Males (%) | (17) 64.7 | (25) 68 | 1.0 |
| Duration of diabetes (years) | (17) 9.1 ± 2.0 (0–27) | (25) 7.7 ± 1.4 (0–20) | 0.6 |
| Duration of foot ulcer (days) | (17) 38.8 ± 9.4 (1–150) | (21) 33.5 ± 7.9 (2–135) | 0.7 |
| Duration of admission (days) | (17) 21.2 ± 5.9 (0–78) | (22) 40.9 ± 7.7 (6–130) | 0.06 |
| Ulcer grade 4 | (17) 76.5% | (25) 28% | 0.004 |
| Blood glucose (mmol/L) | (11) 18.2 ± 3.6 (1.2–33.3) | (21) 13.9 ± 1.7 (1.9–31.1) | 0.3 |
| PCV (%) | (12) 23.6 ± 1.4 (16–31) | (22) 29.7 ± 1.6 (13–42) | 0.02 |
| Anaemia | (12) 83.3% | (25) 57.1% | 0.08 |
| White blood cell × 106 | (10) 27.6 ± 3.9 (10.3–54.4) | (21) 16.3 ± 3.6 (1.3–64) | 0.06 |
| Leucocytosis | (10) 100% | (21) 57.1% | 0.03 |
| Renal failure | (8) 37.5% | (17) 11.8% | 0.3 |
| PN | (13) 84.6% | (23) 78.3% | 1.0 |
| PAD | (17) 23.5% | (25) 36% | 0.4 |
Data are mean ± SEM, range and number of subjects or percentage and number of subjects. BG, blood glucose; PAD, peripheral arterial disease; PCV, packed cell volume; PN, peripheral neuropathy.